A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis
一项随机、开放标签研究,旨在比较每日一次或三次服用伊维菌素联合乙胺嗪和阿苯达唑(IDA)与每日一次服用伊维菌素联合阿苯达唑(IA)治疗盘尾丝虫病的耐受性和疗效。
期刊:PLoS Neglected Tropical Diseases
影响因子:3.4
doi:10.1371/journal.pntd.0011365
Opoku, Nicholas O; Doe, Felix; Dubben, Bettina; Fetcho, Nicole; Fischer, Kerstin; Fischer, Peter U; Gordor, Shelter; Goss, Charles W; Gyasi, Michael E; Hoerauf, Achim; Hong, Augustine R; Kanza, Eric; King, Christopher L; Laryea, Ruth; Lew, Daphne; Seidu, Mahmood A; Weil, Gary J